Home › Gastrointestinal Cancers › California › Mountain View
Gastrointestinal Cancers clinical trials in Mountain View, CA
4 studies for Gastrointestinal Cancers are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
RecruitingPhase 1
- Stanford Cancer Center, Palo Alto · 5 mi away
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RecruitingObservational study
- Stanford Cancer Center, Palo Alto · 5 mi away
Gastrointestinal Cancers trials in other cities
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN10 studies
- Los Angeles, CA9 studies
- Dallas, TX8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Cincinnati, OH8 studies
- Arlington, VA8 studies
- San Antonio, TX7 studies
- Baldwin Park, CA7 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer25 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Heart Failure15 studies
- Prostate Cancer15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.